InvestorsHub Logo
Followers 1
Posts 26
Boards Moderated 0
Alias Born 10/22/2019

Re: None

Sunday, 04/05/2020 10:25:27 AM

Sunday, April 05, 2020 10:25:27 AM

Post# of 426501
Vascepa being Gold Standard will Drive Rx Growth.... Vascepa direct to consumer TV ads with specific words, pictures, telling the story of Vascepa being the Only Prescription Medication with proven Death Reductions, Stroke Reductions, Heart Attack Reduction, these results were not shown in generics. Patients want what they see and KNOW works. Patients have never been specifically told about Vascepa. AZ is a Pharma Lord...BECAUSE OF THEIR VERY EFFECTIVE DTC MARKETING! Providers WILL prescribe what patients ask for. The only Pure EPA with indication for claims in the DTC will be Vascepa. LOTS OF MONEY to be made. Trust the user, they will come with effective marketing. Vascepa on majority of formularies and covered because of the indication. Patient ask for Vascepa, Prescriber prescribes because patient asked, Managed Care pays because it is indicated. Many PPIs came after Prilosec however, everyone knew and asked for “The Purple Pill.” Marketing moves and being the Gold Standard drives Rx for a long time.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News